COVID-19 and Cardiovascular Disease

Editor's choice

Videos

Webinars

COVID-19

Articles

Podcast Episodes

  • EP 39: The Year 2020 in Review with Sukh Nijjer

    EP 39: The Year 2020 in Review with Sukh Nijjer

    In the first Parallax episode of 2021, Ankur welcomed back Sukh Nijjer from Imperial College London to review the most impactful events and advances in cardiology from 2020.

    Which COVID19 patients require risk stratification with a stress test? What are the take-home messages for physicians taking care of patients diagnosed with COVID19? What were the key trials of 2020? What can we learn from the negative results of the STRENGHT study? How have studies like STOP-AF influenced clinical practice?

  • 27: The new reality of CVD care with Grant W Reed, Director of the Cleveland Clinic’s STEMI program

    27: The new reality of CVD care with Grant W Reed, Director of the Clevelan...

    Ankur Kalra asks Grant W Reed, Director of the Cleveland Clinic’s STEMI program, to reflect on the actions they took and the challenges of delaying cardiovascular procedures in the wake of the coronavirus pandemic. Dr Reed offers insight on the factors that influenced the Cleveland Clinic’s STEMI policy for COVID-19. Ankur and Grant discuss the triage considerations for patients with structural heart disease and the steps the clinic took to protect its healthcare workers.

  • How COVID-19 has changed the educational paradigm - Steve Elias

    How has education and training for physicians changed in light of the COVID-19 pandemic? Steve Elias, MD, meets with key industry figures from AngioDynamics, Philips, Medtronic as well as event organisers, Radcliffe Group, to gain a different perspective, this time from industry on their response to the recent pandemic.

EP 39: The Year 2020 in Review with Sukh Nijjer

In the first Parallax episode of 2021, Ankur welcomed back Sukh Nijjer from Imperial College London to review the most impactful events and advances in cardiology from 2020.

Which COVID19 patients require risk stratification with a stress test? What are the take-home messages for physicians taking care of patients diagnosed with COVID19? What were the key trials of 2020? What can we learn from the negative results of the STRENGHT study? How have studies like STOP-AF influenced clinical practice?

Management of Acute Coronary Syndromes During the Coronavirus Disease 2019 Pandemic: Deviations from Guidelines and Pragmatic Considerations for Patients and Healthcare Workers

Creative Commons Licence
 
Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

International guidelines provide clinicians with evidence-based recommendations on how to manage patients presenting with acute coronary syndromes (ACS).

Coronavirus Disease 2019 and Cardiac Arrhythmias

Creative Commons Licence
 
Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

In the last months of 2019 and the beginning of 2020, a novel disease appeared, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a very contagious virus, which causes coronavirus disease 2019 (COVID-19). The clinical manifestations of this virus in humans vary widely from asymptomatic to severe, with diverse symptomatology and even death.

Gone, but not Forgotten

Creative Commons Licence
 
Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

The direct impact of coronavirus disease 2019 (COVID-19) has resulted in a shift from inpatient to offsite care, as bed utilisation is appropriated to COVID-19 patients or potential COVID-19 patients.

The Coronavirus Disease 2019 Outbreak Highlights the Importance of Sex-sensitive Medicine

Creative Commons Licence
 
Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

While 2020 is only halfway through, we have already experienced a historical year in global healthcare with a high societal impact. When the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were reported in China at the end of 2019, few people realised we would all be affected by a global pandemic several months later.

Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach

Creative Commons Licence
 
Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

This review focuses on the implications of coronavirus disease 2019 (COVID-19) in the heart failure (HF) population. First of all, we will describe the cardiovascular implications of COVID-19 and the new practices surrounding the use of telehealth to follow up and triage patients with HF.

Pages

Subscribe to RSS - COVID-19 and Cardiovascular Disease